End-of-day quote
Shenzhen S.E.
06:00:00 2024-06-03 pm EDT
5-day change
1st Jan Change
9.29
CNY
+1.20%
-0.85%
-9.10%
Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback announced on February 8, 2022, has expired with 4,187,406 shares, representing 0.26% for CNY 40.05 million.
The company expired its plan on August 7, 2022.
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 25
CI
Anhui Anke Biotechnology Co., Ltd. Proposes Final Dividend for 2023
Mar. 27
CI
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 27
CI
Anke Biotechnology's Unit Passes US FDA Workplace Inspection
Feb. 18
MT
Anhui Anke Biotechnology Co., Ltd. agreed to acquire 11.31% stake in Anhui Xinhuakun Biological Engineering Co., Ltd. from a group of shareholders for CNY 10.3 million.
Dec. 12
CI
Anhui Anke Biotechnology Gets Nod to Market Breast Cancer Drug
Nov. 01
MT
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-24
CI
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-23
CI
Anhui Anke Biotechnology Co., Ltd. Declares Final Cash Dividend for 2022 on A Shares, Payable on 19 May 2023
23-05-15
CI
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-27
CI
Anhui Anke Biotechnology Co., Ltd. Approves Cash Dividend for 2022
23-04-21
CI
Anhui Anke Biotechnology Co., Ltd. Proposes Final Cash Dividend for the Year of 2022
23-03-27
CI
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-27
CI
Anhui Anke Biotechnology Co., Ltd. Announces Board Elections
22-12-26
CI
Anhui Anke Biotechnology Unit Gets Regulatory Nod For Anti-Postpartum Hemorrhage Drug
22-12-23
MT
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-25
CI
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
22-08-24
CI
Tranche Update on Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2022.
22-08-08
CI
Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback announced on February 8, 2022, has expired with 4,187,406 shares, representing 0.26% for CNY 40.05 million.
22-08-06
CI
Tranche Update on Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2022.
22-07-04
CI
Anhui Anke Biotech to Form mRNA Vaccine JV With Startup
22-05-17
MT
Anhui Anke Biotechnology Co., Ltd. Announces Cash Dividend for the Year 2021, Payable on 13 May 2022
22-05-10
CI
Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-04-27
CI
Anhui Anke Biotechnology Co., Ltd. Approves Profit Distribution
22-04-21
CI
Tranche Update on Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2022.
22-04-06
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Anhui Anke Biotechnology Group Co Ltd is a China-based company mainly engaged in the research and development, production and sales of genetic engineering drugs and biological detection reagents. The Company's products mainly include biological products, modern Chinese patent medicines, chemical synthetic drugs, and peptide drugs. The Company's subsidiary business covers the research and development, production and sales of modern Chinese patent medicines, chemical synthetic drugs, peptide drugs, forensic DNA testing, cell drugs and other products.
More about the company
Last Close Price
9.29
CNY
Average target price
19.54
CNY
Spread / Average Target
+110.33%
Consensus
1st Jan change
Capi.
-9.10% 2.15B -0.28% 90.59B -0.92% 38.99B -9.57% 34.09B -17.98% 15.02B -6.74% 13.17B -9.76% 11.88B -47.31% 10.65B +7.19% 9.25B +137.06% 9.02B
Biopharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1